Amarin Corp Plc (AMRN)

[VuBru]

Pyr - Re: your #3, statins do not work via the same mechanism as EPA or aspirin (aspirin and EPA are not really the same either). These distinct beneficial mechanisms are why they might have additive effects rather than duplicate effects. EPA also addresses two distinct mechanisms which might be complementary in terms of reducing risk (Trig lowering and anti-inflammatory). R-It will see whether that is the case.

I think I understand your short argument, that you make less money but with less risk. I disagree with your thesis that chances of R-It success are as low as you postulate. Based on this, I am willing to take JL's asymmetric bet.